Abstract
Rationale
Recent reports have demonstrated that gamma-aminobutyric acid (GABA)-ergic compounds attenuate the reinforcing effects of cocaine in rats. Baclofen, a GABAB receptor agonist, appears to be particularly effective in this respect, suggesting that GABAB receptor activation is critically involved in mediating anti-cocaine effects. Amphetamine, like cocaine, is a psychomotor stimulant with high abuse potential in humans.
Objectives
The purpose of the present investigation was to determine whether baclofen may attenuate the reinforcing effects of d-amphetamine (dAMPH) in rats. Dose–response curves were generated to examine the effect of three doses of baclofen (1.8, 3.2 or 5.6 mg/kg, IP) on dAMPH intravenous self-administration (IVSA). Separate groups were trained to self-administer two doses of dAMPH (0.1 mg/kg or 0.2 mg/kg per injection) under either a fixed-ratio (FR) or progressive ratio (PR) schedule of reinforcement. Microdialysis was performed in an additional group of rats to examine the effect of baclofen on dAMPH-induced increases in dopamine (DA) efflux in the nucleus accumbens (NAc).
Results
Pretreatment with baclofen produced dose-dependent reductions in responding for dAMPH under both the FR and PR schedules, and attenuated dAMPH-induced increases in DA levels in the NAc.
Conclusion
These results add to previous findings showing that baclofen attenuates the reinforcing effects of psychostimulant drugs, and suggest that further investigation into the effects of GABAB receptor agonists on drug self-administration is warranted.
Similar content being viewed by others
References
Addolorato G, Caputo F, Capristo E, Colombo G, Gessa GL, Gasbarrini G (2000) Ability of baclofen in reducing alcohol craving and intake. II. Preliminary clinical evidence. Alcohol Clin Exp Res 24:67–71
Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, Columbo G, Gessa GL, Gasbarrini G (2002) Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 112:226–229
Agmo A, Medrano A, Garrido N, Alonso P (1997) GABAergic drugs inhibit amphetamine-induced distractability in the rat. Pharmacol Biochem Behav 58:119–126
Ahn S, Phillips AG (2002) Modulation by central and basolateral amygdalar nuclei of dopaminergic correlates of feeding to satiety in the rat nucleus accumbens and medial prefrontal cortex. J Neurosci 22:10958–10965
Alderson HL, Latimer MP, Blaha CD, Phillips AG, Winn P (2004) An examination of d-amphetamine self-administration in pedunculopontine tegmental nucleus-lesioned rats. Neuroscience 125:349–358
Brebner K, Froestl W, Andrews M, Phelan, R, Roberts DCS (1999) The GABAB agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology 38:1797–1804
Brebner K, Phelan R, Roberts DCS (2000a) Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology 148:314–321
Brebner K, Phelan R, Roberts DCS (2000b) Intra-VTA baclofen attenuates cocaine self-administration on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav 66:857–862
Brebner K, Froestl W, Roberts DCS (2002a) The GABAB antagonist CGP56433A attenuates the effect of baclofen on cocaine, but not heroin self-administration in the rat. Psychopharmacology 160:49–55
Brebner K, Childress AR, Roberts DCS (2002b) A potential role for GABAB agonists in the treatment of psychostimulant addiction. Alcohol Alcohol 37:478–484
Campbell UC, Lac ST, Carroll ME (1999) Effects of baclofen on maintenance and reinstatement of intravenous cocaine self-administration in rats. Psychopharmacology 143:209–214
Childress AR, Franklin T, McElgin W, Acton P, O’Brien CP (2002) Neuroimaging of cocaine craving states: cessation, stimulant administration and drug cue paradigms. In: CPDD: Proceedings of the 64th Annual Scientific Meeting abstracts
Colombo G, Agabio R, Carai MA, Lobina C, Pani M, Reali R, Addolorato G, Gessa GL (2000) Ability of baclofen in reducing alcohol intake and withdrawal severity. I. Preclinical evidence. Alcohol Clin Exp Res 24:58–66
Corrigall WA, Coen KM, Adamson KL, Chow BL, Zhang J (2000) Response of nicotine self-administration in the rat to manipulations of mu-opioid and γ-aminobutryic acid receptors in the ventral tegmental area. Psychopharmacology 149:107–114
Cousins MS, Stamat HM, de Wit H (2000) Effects of d-amphetamine and the GABA(B) agonist baclofen on cigarette smoking and nicotine craving. CPDD 62nd Annual Meeting abstracts, 32
Cousins MS, Roberts DCS, de Wit H (2002) GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug Alcohol Depend 65:209–220
Di Ciano P, Everitt BJ (2003) The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28:510–518
Di Ciano P, Everitt BJ (2004) Contribution of the ventral tegmental area to cocaine-seeking maintained by a drug-paired conditioned stimulus in rats. Eur J Neurosci 19:1661–1667
Di Ciano P, Coury A, Depoortere RY, Egilmez Y, Lane JD, Emmett-Oglesby MW, Lepiane FG, Phillips AG, Blaha CD (1995) Comparison of changes in extracellular dopamine concentrations in the nucleus accumbens during intravenous self-administration of cocaine or d-amphetamine. Behav Pharmacol 6:311–322
Echo JA, Lamonte N, Ackerman TF, Bodnar RJ (2002) Alterations in food intake elicited by GABA and opioid agonists and antagonists administered into the ventral tegmental region of rats. Physiol Behav 76:107–116
Fadda P, Scherma M, Fresu A, Collu M, Fratta W (2003) Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse 50:1–6
Fattore L, Cossu G, Martellotta MC, Fratta W (2002) Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol 37:495–498
Fischer JF, Cho AK (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203–209
Gerasimov MR, Ashby CR Jr, Gardner EL, Mills MJ, Brodie JD, Dewey SL (1999) Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34:11–19
Higgs S, Barber DJ (2004) Effects of baclofen on feeding behaviour examined in the runway. Prog Neuropsychopharmacol Biol Psychiatry 28:405–408
Hotsenpiller G, Wolf ME (2003) Baclofen attenuates conditioned locomotion to cues associated with cocaine administration and stabilizes extracellular glutamate levels in rat nucleus accumbens. Neuroscience 118:123–134
Kalivas PW, Duffy P, Eberhardt H (1990) Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther 253:858–866
Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723
Li SM, Yin LL, Ren YH, Pan LI, Zheng JW (2001) GABA(B) receptor agonist baclofen attenuates the development and expression of d-methamphetamine-induced place preferences in rats. Life Sci 70:349–356
Ling W, Shoptaw S, Majewska D (1998) Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 18:403–404
Lyness WH, Friedle NM, Moore KE (1979) Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol Biochem Behav 11:553–556
Morgan AE, Dewey SL (1998) Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28:60–65
Munzar P, Kutkat SW, Miller CR, Goldberg SR (2000) Failure of baclofen to modulate discriminative stimulus effects of cocaine or methamphetamine in rats. Eur J Pharmacol 408:169–174
National Institute on Drug Abuse (2002) NIDA research report: methamphetamine abuse and addiction. National Institutes of Health Publication #02-4210, Rockland
Negus SS, Mello NK, Fivel PA (2000) Effects of GABA agonists and GABA-A receptor modulators on cocaine discrimination in rhesus monkeys. Psychopharmacology 152:398–407
Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego
Phillis BD, Ong J, White JM, Bonielle C (2001) Modification of d-amphetamine-induced responses by baclofen in rats. Psychopharmacology 153:277–284
Ranaldi R, Poeggel K (2002) Baclofen decreases methamphetamine self-administration in rats. NeuroReport 13:1107–1109
Richardson NR, Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1–11
Roberts DCS, Andrews MM (1997) Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology 131:271–277
Roberts DCS, Brebner K (2000) GABA modulation of cocaine self-administration. Ann N Y Acad Sci 909:145–158
Roberts DCS, Andrews MM, Vickers GJ (1996) Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15:417–423
Shoaib M, Swanner LS, Beyer CE, Goldberg SR, Schindler CW (1998) The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol 9:195–206
Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD (2003) Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 165:359–369
Shoptaw S, Yang X, Rotheram-Fuller EJ, Hsieh YC, Kintaudi PC, Charuvastra VC, Ling W (2003) Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use. J Clin Psychiatry 64:1440–1448
Steninger B, Kretschmer BD (2003) Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus. Exp Brain Res 149:422–430
Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102–4108
Ward BO, Somerville EM, Clifton PG (2000) Intraaccumbens baclofen selectively enhances feeding behavior in the rat. Physiol Behav 68:463–468
Westerink BH, Kwint HF, deVries JB (1996) The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci 16:2605–2611
Westerink BH, Kwint HG, deVries JB (1997) Eating-induced dopamine release from mesolimbic neurons is mediated by NMDA receptors in the ventral tegmental area: a dual-probe microdialysis study. J Neurochem 69:662–668
Xi ZX, Stein EA (1999) Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther 290:1369–1374
Yoshida M, Yokoo H, Tanaka T, Emoto H, Tanaka M (1994) Opposite changes in mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res 636:111–114
Yun IA, Wakabayashi KT, Fields HL, Nicola SM (2004) The ventral tegmental area is required for the behavioral and nucleus accumbens neuronal firing to incentive cues. J Neurosci 24:2923–2933
Acknowledgements
This research was funded by a grant from the Canadian Institutes for Health Research (CIHR) to A.G.P. and a CIHR postdoctoral fellowship to K.B. The authors wish to thank K.S. for microdialysis and HPLC technical support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brebner, K., Ahn, S. & Phillips, A.G. Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology 177, 409–417 (2005). https://doi.org/10.1007/s00213-004-1968-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-004-1968-6